Agree with You! CytRx's PPS is manipulated, undervalued, because no present value of contracted and expected income, especially MS payments of Orpha and Aldox (up to 120 + 343 M).
IMO Soon has to file the NDA before finishing vaccine trials to register results. (Maybe he done, just it's confidental like NC plan and activity.
We'll see it once, not mentioning LADR deal ASAP!
No investor knows when, that's why impossible to calculate a real present value! But it's not 0, so PPS must be higher than MC!
Waiting for answers and PR!
GLTY
News 
Market Data 
Discover 
